Antiretroviral drug concentrations in semen of HIV-1 infected men

被引:77
作者
Taylor, S [1 ]
Pereira, AS
机构
[1] Univ Birmingham, Div Immun & Infect, PHLS Antiviral Susceptibil, Birmingham B15 2TT, W Midlands, England
[2] Birmingham Heartlands Hosp, Dept Sexual Med, Birmingham, W Midlands, England
[3] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
关键词
HIV; semen; antiretrovirals; drug concentrations; pharmacokinetics; protein binding;
D O I
10.1136/sti.77.1.4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Because semen is a major vehicle for the sexual transmission of HIV-1, control of viral replication within the sanctuary of the male genital tract should be a goal of antiretroviral therapy. Local immune responses, virus specific factors, and the degree of viral and cellular trafficking all appear to be important in controlling viral replication and evolution. However, the most important factor influencing viral replication and evolution within the male genital tract may be the disposition of antiretroviral agents into genital tissues and fluids. This review proposes possible mechanisms of antiretroviral distribution into the male genital tract by using other sanctuary barriers; such as the placenta, renal tubules, and blood-brain barrier; as models. In addition, this review summarises recent clinical studies regarding the disposition of currently available antiretroviral drugs into the seminal plasma and discusses some of the difficulties in interpreting drug concentration in the genital tract.
引用
收藏
页码:4 / 11
页数:8
相关论文
共 66 条
[31]   PHARMACOKINETICS OF QUINOLONE DERIVATIVES IN THE PROSTATE [J].
MADSEN, PO ;
AAGAARD, J .
INFECTION, 1991, 19 :S154-S156
[32]   PASSAGE OF CHEMICALS INTO HUMAN AND ANIMAL SEMEN - MECHANISMS AND SIGNIFICANCE [J].
MANN, T ;
LUTWAKMANN, C .
CRC CRITICAL REVIEWS IN TOXICOLOGY, 1982, 11 (01) :1-14
[33]   Indinavir-based treatment of HIV-1 infected patients:: efficacy in the central nervous system [J].
Martin, C ;
Sönnerborg, A ;
Svensson, JO ;
Ståhle, L .
AIDS, 1999, 13 (10) :1227-1232
[34]   Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus [J].
Molla, A ;
Vasavanonda, S ;
Kumar, G ;
Sham, HL ;
Johnson, M ;
Grabowski, B ;
Denissen, JF ;
Kohlbrenner, W ;
Plattner, JJ ;
Leonard, JM ;
Norbeck, DW ;
Kempf, DJ .
VIROLOGY, 1998, 250 (02) :255-262
[35]   The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1 [J].
Moore, KHP ;
Barrett, JE ;
Shaw, S ;
Pakes, GE ;
Churchus, R ;
Kapoor, A ;
Lloyd, J ;
Barry, MG ;
Back, D .
AIDS, 1999, 13 (16) :2239-2250
[36]  
PEREIRA A, 2000, 7 C RETR OPP INF
[37]   Nucleoside analogues achieve high concentrations in seminal plasma: Relationship between drug concentration and virus burden [J].
Pereira, AS ;
Kashuba, ADM ;
Fiscus, SA ;
Hall, JE ;
Tidwell, RR ;
Troiani, L ;
Dunn, JA ;
Eron, JJ ;
Cohen, MS .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) :2039-2043
[38]   DRUGS IN SEMEN [J].
PICHINI, S ;
ZUCCARO, P ;
PACIFICI, R .
CLINICAL PHARMACOKINETICS, 1994, 26 (05) :356-373
[39]   Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor [J].
Polli, JW ;
Jarrett, JL ;
Studenberg, SD ;
Humphreys, JE ;
Dennis, SW ;
Brouwer, KR ;
Woolley, JL .
PHARMACEUTICAL RESEARCH, 1999, 16 (08) :1206-1212
[40]  
REIJERS M, 2000, 7 C RETR OPP INF